You are here

Industry News

Feb 08, 2019

Here's a statement that wasn't true 10 or even five years ago: Consumer choice is driving healthcare transformation. As the expectations and experiences influencing choice change, healthcare must evolve to meet consumers when, where and how they are making those choices.

This comes as no surprise to us in marketing and brand experience—we see it every day, in every interaction. It's happened in all other sectors of our economy, and now consumerism is dramatically changing the...

Feb 07, 2019

My latest trip to Davos to participate in the World Economic Forum last month was a productive and exciting gaze into the future of healthcare delivery: a world of healthcare with no address, greater immersion in population health strategies and a global push to advance mental health treatment.

It's a sizable agenda for four days and many of us emerged with a renewed commitment to partner to improve outcomes and reduce costs, to continue our investments in technology that's radically...

Feb 07, 2019

A draft version of House Democrats' upcoming Medicare for All bill proposes a national system that would pre-pay hospitals with lump sums while keeping a fee-for-service model for individual physicians.

The 127-page draft, obtained by Modern Healthcare and dated Jan. 14, in many ways tracks with the system laid out in the 2017 bill from Sen. Bernie Sanders (I-Vt.) who brought Medicare for All to the forefront of progressive Democratic policy. But where the Sanders bill sidestepped...

Feb 07, 2019

Providence St. Joseph Health leveraged data to reduce its knee replacement costs by more than $1 million a year.

The Renton, Wash.-based integrated health system first analyzed what drove variation across its 51-hospital network and targeted the use of antibiotic-infused bone cement. Hypothetically, it can stave off infections.

Feb 07, 2019

Tenet Healthcare Corp. announced Thursday it has extended its long-term contract with Cerner Corp.

The Dallas-based for-profit hospital chain did not disclose the length or share financial terms of the contract, but said it will continue working with the electronic health records vendor to make its information systems more efficient across its hospitals and provide a unified experience for patients and clinicians.

Paola Arbour, Tenet's chief information officer, told Modern...

Feb 07, 2019

The Trump administration is calling for pharmacy benefit managers to disclose to health plans the fees that they get from drug companies for administrative services as part of a bid to boost transparency among PBMs.

The fee transparency requirement is part of a proposed rule unveiled last week that also would eliminate anti-kickback statute safe harbor protections for drug rebates, while creating two new ones.

The rule proposes to create a safe harbor for discounts provided...

Feb 07, 2019

Health policy played a surprisingly robust role in President Donald Trump’s 2019 State of the Union address.

The president laid out an ambitious set of health goals in his speech Tuesday to Congress and the nation, including reining in drug prices, ending the transmission of HIV in the U.S. during the next decade and dedicating more resources to fighting childhood...

Feb 06, 2019

The top federal prosecutor in Philadelphia has filed suit to stop a not-for-profit from opening a first-in-the-nation supervised drug injection site to address the city's opioid problem.

The lawsuit pits U.S. Attorney William McSwain's stance on safe injection sites against those of Philadelphia's mayor, district attorney and a former Pennsylvania governor. McSwain believes supporters should try to change the laws, not break them.

"Normalizing the use of deadly drugs like...

Feb 06, 2019

House Democrats this week brought the Affordable Care Act back to the forefront as a top priority, albeit without clear and near-term policy implications.

The legislation announced in a key House health panel hearing on Wednesday targets the Trump administration policies that affect the law. The bills aren't likely to go anywhere this Congress with the Senate and White House still in Republican control, but lawmakers once again highlighted the divide in the Democratic and GOP...

Feb 06, 2019
House and Senate lawmakers reintroduced a bill on Tuesday to combat tactics brand-name drug companies use to stymie generic and biosimilar competition.

Sens. Chuck Grassley (R-Iowa) and Patrick Leahy (D-Vt.) reintroduced the Creating and Restoring Equal Access to Equivalent Samples Act, or Creates Act, which generated immense opposition from the pharmaceutical industry.

"For too long, a few predatory name brand companies have used anticompetitive strategies to delay entry of lower...